Patent ID: 9220830
Filing Date: 2015-12-29
Classification: A61M

Abstract:
1. An apparatus for extracorporeal blood treatment comprising: at least one treatment unit including at least one first chamber and at least one second chamber separated from the first chamber by a semipermeable membrane; at least one blood removal line connected to an inlet port of the first chamber and predisposed to remove blood from a patient; at least one blood return line connected with an outlet port of the first chamber and predisposed to return treated blood to the patient, the blood removal line, the blood return line and the first chamber comprise an extracorporeal blood circuit; at least one infusion line of a replacement fluid connected with the extracorporeal circuit or directly connectable with a patient; at least one dialysis line connected to an inlet port to the second chamber; at least one fluid evacuation line connected to an outlet port of the second chamber; a sensor system configured to determine: a first regulating device active on at least one of the extracorporeal circuit and the fluid evacuation line, and configured to regulate an ultrafiltration rate (UFR) or a transmembrane pressure (TMP) between the first and the second chamber of the treatment unit, and a control unit receiving data from the sensor system and in communication with the first regulating device, wherein the control unit is configured to perform: a) at least at a control instant (τ), a control procedure comprising: the control unit further performs: b) at least at a setting instant (τ), a setting sequence of the transmembrane pressure, said setting sequence comprising: